Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant

J. F. Codrington, H. W. Li, F. Kutlar, L. H. Gu, M. Ramachandran, T. H.J. Huisman

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Hb A2 and its variant B22δ2 16(A13)Gly→Arg) were quantitated in the blood of subjects with three different types of β-thalassemia and with the δ-B2 anomaly in cis or in trans to the β-thalassemia determinant. In one family, the δ-B2 mutation was in cis to a newly discovered codon 47 (+A) frameshift. The levels of Hbs A2 and B2 were nearly the same and approximately 70% higher than those in simple Hb B2 heterozygotes. In two additional families, the δ-B2 variant was in trans to either a deletion β-thalassemia (1,393 bp) involving part of the β-globin gene and part of the β-globin gene promoter, or to the - 88 C→T promoter mutation. In both instances, the Hb B2 level was increased by approximately 80%, but the Hb A2 level was increased by approximately 270% and 200%, respectively. These data indicate two mechanisms that will cause an increase in δ chain production. One is consistent with a general mechanism concerning the relative excess of α chains in β chain deficiencies which will combine with δ chains to form variable levels of Hb A2 dependent on the severity of the β chain deficiency. The second concerns the loss of β-globin gene promoter activity, perhaps by an absence of (or decreased) binding of specific protein(s) to this segment of DNA and a concomitant increase in δ-globin gene promoter activity in cis.

Original languageEnglish (US)
Pages (from-to)1246-1249
Number of pages4
JournalBlood
Volume76
Issue number6
StatePublished - Jan 1 1990

Fingerprint

Thalassemia
Globins
Genes
Mutation
Heterozygote
varespladib methyl
Codon
Carrier Proteins
Blood
hemoglobin A2'
DNA
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Codrington, J. F., Li, H. W., Kutlar, F., Gu, L. H., Ramachandran, M., & Huisman, T. H. J. (1990). Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant. Blood, 76(6), 1246-1249.

Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant. / Codrington, J. F.; Li, H. W.; Kutlar, F.; Gu, L. H.; Ramachandran, M.; Huisman, T. H.J.

In: Blood, Vol. 76, No. 6, 01.01.1990, p. 1246-1249.

Research output: Contribution to journalArticle

Codrington, JF, Li, HW, Kutlar, F, Gu, LH, Ramachandran, M & Huisman, THJ 1990, 'Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant', Blood, vol. 76, no. 6, pp. 1246-1249.
Codrington JF, Li HW, Kutlar F, Gu LH, Ramachandran M, Huisman THJ. Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant. Blood. 1990 Jan 1;76(6):1246-1249.
Codrington, J. F. ; Li, H. W. ; Kutlar, F. ; Gu, L. H. ; Ramachandran, M. ; Huisman, T. H.J. / Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant. In: Blood. 1990 ; Vol. 76, No. 6. pp. 1246-1249.
@article{e7b0b0153f8d4b06b17ee5515943391f,
title = "Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant",
abstract = "Hb A2 and its variant B2 (α2δ2 16(A13)Gly→Arg) were quantitated in the blood of subjects with three different types of β-thalassemia and with the δ-B2 anomaly in cis or in trans to the β-thalassemia determinant. In one family, the δ-B2 mutation was in cis to a newly discovered codon 47 (+A) frameshift. The levels of Hbs A2 and B2 were nearly the same and approximately 70{\%} higher than those in simple Hb B2 heterozygotes. In two additional families, the δ-B2 variant was in trans to either a deletion β-thalassemia (1,393 bp) involving part of the β-globin gene and part of the β-globin gene promoter, or to the - 88 C→T promoter mutation. In both instances, the Hb B2 level was increased by approximately 80{\%}, but the Hb A2 level was increased by approximately 270{\%} and 200{\%}, respectively. These data indicate two mechanisms that will cause an increase in δ chain production. One is consistent with a general mechanism concerning the relative excess of α chains in β chain deficiencies which will combine with δ chains to form variable levels of Hb A2 dependent on the severity of the β chain deficiency. The second concerns the loss of β-globin gene promoter activity, perhaps by an absence of (or decreased) binding of specific protein(s) to this segment of DNA and a concomitant increase in δ-globin gene promoter activity in cis.",
author = "Codrington, {J. F.} and Li, {H. W.} and F. Kutlar and Gu, {L. H.} and M. Ramachandran and Huisman, {T. H.J.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "76",
pages = "1246--1249",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Observations on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant

AU - Codrington, J. F.

AU - Li, H. W.

AU - Kutlar, F.

AU - Gu, L. H.

AU - Ramachandran, M.

AU - Huisman, T. H.J.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Hb A2 and its variant B2 (α2δ2 16(A13)Gly→Arg) were quantitated in the blood of subjects with three different types of β-thalassemia and with the δ-B2 anomaly in cis or in trans to the β-thalassemia determinant. In one family, the δ-B2 mutation was in cis to a newly discovered codon 47 (+A) frameshift. The levels of Hbs A2 and B2 were nearly the same and approximately 70% higher than those in simple Hb B2 heterozygotes. In two additional families, the δ-B2 variant was in trans to either a deletion β-thalassemia (1,393 bp) involving part of the β-globin gene and part of the β-globin gene promoter, or to the - 88 C→T promoter mutation. In both instances, the Hb B2 level was increased by approximately 80%, but the Hb A2 level was increased by approximately 270% and 200%, respectively. These data indicate two mechanisms that will cause an increase in δ chain production. One is consistent with a general mechanism concerning the relative excess of α chains in β chain deficiencies which will combine with δ chains to form variable levels of Hb A2 dependent on the severity of the β chain deficiency. The second concerns the loss of β-globin gene promoter activity, perhaps by an absence of (or decreased) binding of specific protein(s) to this segment of DNA and a concomitant increase in δ-globin gene promoter activity in cis.

AB - Hb A2 and its variant B2 (α2δ2 16(A13)Gly→Arg) were quantitated in the blood of subjects with three different types of β-thalassemia and with the δ-B2 anomaly in cis or in trans to the β-thalassemia determinant. In one family, the δ-B2 mutation was in cis to a newly discovered codon 47 (+A) frameshift. The levels of Hbs A2 and B2 were nearly the same and approximately 70% higher than those in simple Hb B2 heterozygotes. In two additional families, the δ-B2 variant was in trans to either a deletion β-thalassemia (1,393 bp) involving part of the β-globin gene and part of the β-globin gene promoter, or to the - 88 C→T promoter mutation. In both instances, the Hb B2 level was increased by approximately 80%, but the Hb A2 level was increased by approximately 270% and 200%, respectively. These data indicate two mechanisms that will cause an increase in δ chain production. One is consistent with a general mechanism concerning the relative excess of α chains in β chain deficiencies which will combine with δ chains to form variable levels of Hb A2 dependent on the severity of the β chain deficiency. The second concerns the loss of β-globin gene promoter activity, perhaps by an absence of (or decreased) binding of specific protein(s) to this segment of DNA and a concomitant increase in δ-globin gene promoter activity in cis.

UR - http://www.scopus.com/inward/record.url?scp=0025118721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025118721&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 1246

EP - 1249

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -